Daniela Niemeyer Selected Research

Daniela Niemeyer Research Topics

7	COVID-19 01/2022 - 01/2021
6	Infections 01/2022 - 10/2011
3	Virus Diseases (Viral Diseases) 11/2021 - 12/2019
2	Inflammation (Inflammations) 01/2022 - 11/2021
1	Human Influenza (Influenza) 12/2022
1	Fever (Fevers) 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Lung Diseases (Lung Disease) 11/2021
1	Thrombosis (Thrombus) 11/2021
1	Severe Acute Respiratory Syndrome 01/2020

4	CytokinesIBA 12/2021 - 10/2011
3	RNA (Ribonucleic Acid)IBA 12/2022 - 03/2021
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2021
3	InterferonsIBA 01/2022 - 01/2018
2	AntibodiesIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2018
2	EnzymesIBA 01/2018 - 12/2011
1	Interferon Type IIBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	AntigensIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	imdevimabIBA 01/2022
1	QuercetinIBA 11/2021
1	navitoclaxIBA 11/2021
1	Dasatinib (BMS 354825)FDA Link 11/2021
1	SenotherapeuticsIBA 11/2021
1	Complement System Proteins (Complement)IBA 11/2021
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 03/2021
1	Interferon-betaIBA 03/2021
1	Interleukin-6 (Interleukin 6)IBA 03/2021
1	ProteomeIBA 01/2021
1	Antiviral Restriction FactorsIBA 01/2021
1	UbiquitinIBA 01/2021
1	allicinIBA 01/2021
1	Virus ReceptorsIBA 01/2020
1	Beclin-1IBA 12/2019
1	PolyproteinsIBA 01/2018
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 12/2011
1	CalcineurinIBA 10/2011
1	Interleukin-2 (IL2)IBA 10/2011